.jpg)
.png)
All
“If you would not be forgotten as soon as you are dead and rotten, either write things worth reading or do things worth the writing.” – Benjamin Franklin The National Lipid Association is the premier organization dedicated to advancing our knowledge about the optimal approach to diagnosing and... more
Alan Brown, MD, FNLA President It has been an honor to serve as the President of the National Lipid Association (NLA) for the 2018-19 organizational year, and I look forward to the rest of my term through the 2019 Scientific Sessions. I hope everyone had a wonderful holiday and want to... more
I'm happy to give you an update on an important initiative the NLA and its partners are pursuing to kick off 2014. Just more than a month ago the National Lipid Association submitted a proposal to the National Center for Health Statistics (NCHS), the federal agency responsible for revising the... more
Thank you for joining the NLA's "Making LDL Make Sense: A Guideline-Based Roadmap for Primary and Specialty Care Clinicians" Webinar. Select the appropriate certificate below. You can then type in your name and print or save a copy for your records. For questions related to this... more
The 21 Day Challenge The NLA is committed to diversity, equity, and inclusion as a core tenant of the organization. The 21 Day Challenge is sponsored by the NLA Diversity, Equity & Inclusion Task Force. The DEI Task Force challenges you to review all 21 content items and... more
Chicago-area cardiologist assumes role during NLA Scientific Sessions in Las Vegas JACKSONVILLE, Fla. — Alan S. Brown, MD, FNLA, officially assumed the role of National Lipid Association (NLA) President at the annual Scientific Sessions in Las Vegas on Sunday after serving for the past year... more
.session-row { background-color: #0f8e44; color: white } .programming-row { background-color: #1a1f1b; color: white } .education-row { background-color: #cddc28; color: black; } table tr td:nth-child(1... more
Regeneron Pharmaceuticals, Inc. today announced that the New England Journal of Medicine (NEJM) published positive results from the Phase 3 trial of evinacumab in 65 patients with homozygous familial hypercholesterolemia (HoFH). Evinacumab is an investigational medicine that... more
It is with great pleasure that I update all with the wonderful progress being made by the career development committee. The committee chair, Binh An P. Phan, MD, FNLA, and members come from all regions of the country and from all disciplines. The vitality of our organization is enhanced because of... more